CPT code 85610: Prothrombin time billing and 2026 fee schedule

Key Takeaways

CPT code 85610 reports the prothrombin time (PT) test, which also covers the INR calculation derived from PT results.

Medicare covers 85610 under NCD 190.17 for anticoagulant monitoring, bleeding disorder evaluation, and liver function assessment.

Medicare pays 85610 under the Clinical Laboratory Fee Schedule at one national rate, not through RVUs or locality adjustments.

Missing the correct ICD-10 code or ordering physician documentation are the two most common denial triggers for 85610 claims.

Pabau’s claims management software links lab orders directly to CPT and ICD-10 codes, reducing manual entry errors on coagulation billing.

The official AMA CPT code set descriptor for 85610 is: Prothrombin time. The code sits in the Hematology and Coagulation subsection of the Pathology and Laboratory section (80000-89398). It reports a single test performed on a venous blood sample. The test measures how long the extrinsic coagulation pathway takes to form a fibrin clot. The result is reported in seconds, alongside the INR (International Normalized Ratio) calculated from that result. Both values come from a single specimen draw and are billed under 85610 as one unit of service.

This guide covers CPT code 85610 from every billing angle. You get the clinical indications that establish medical necessity, the ICD-10 codes that pair with it, and the 2026 fee schedule. It also covers modifier rules and the denial patterns coders see most often.

Clinical indications: When is CPT 85610 ordered?

Medical necessity for CPT code 85610 hinges on a documented clinical indication. The Centers for Medicare and Medicaid Services (CMS) recognizes three primary categories under NCD 190.17.

• Anticoagulant therapy monitoring. Warfarin (Coumadin) dosing requires regular PT/INR checks. Most patients on stable warfarin therapy are tested every four to six weeks. Newly initiated therapy or dose adjustments require more frequent monitoring, sometimes weekly.
• Bleeding disorder evaluation. Deficiencies in coagulation factors I, II, V, VII, or X all prolong the PT result. Ordering physicians use 85610 to investigate unexplained bleeding, bruising, or pre-surgical coagulation screening.
• Liver function assessment. The liver produces most coagulation factors. A prolonged PT in the context of liver disease (cirrhosis, hepatitis, acute hepatic failure) reflects impaired synthetic function and carries independent prognostic weight.
• Pre-operative clearance. Many surgical teams order a PT panel before procedures with elevated bleeding risk, particularly in patients with unknown coagulation history.
• Vitamin K deficiency. PT-sensitive factors (II, VII, IX, X) are vitamin K-dependent. Malabsorption syndromes, prolonged antibiotic use, and poor nutritional intake can depress them.

Document the specific clinical scenario in the physician order and in the encounter note. A generic order of “routine labs” does not satisfy medical necessity requirements for 85610.

CPT 85610 and INR: Understanding the relationship

A common question from billing staff: is there a separate CPT code for INR? The answer is no. INR is not a standalone test. It is a mathematical ratio calculated from the prothrombin time result using a laboratory-specific ISI (International Sensitivity Index) calibration factor. The formula is: INR = (Patient PT / Mean Normal PT) raised to the power of the ISI.

Because INR is derived from PT, both values are reported under CPT code 85610 as a single billable unit. Billing 85610 twice on the same date to capture “PT” and “INR” separately is incorrect and will be bundled or denied by virtually every payer. The AAPC’s CPT code database confirms this: 85610 includes the INR calculation as part of the descriptor.

ICD-10 codes commonly billed with CPT 85610

Selecting the right ICD-10-CM code is the single most controllable factor in avoiding 85610 denials. The table below maps the most frequently used diagnosis codes to their clinical scenarios, based on CMS coverage data and CMS ICD-10 coding guidelines.

Always use the most specific code available. For warfarin monitoring, Z79.01 combined with the underlying condition code (I48.91 for AFib, I82.401 for DVT, etc.) provides the strongest claim support. Submitting 85610 with only an unspecified coagulation defect code when a more specific diagnosis is known is a common audit flag.

Medicare coverage for CPT code 85610: NCD 190.17

CMS covers prothrombin time testing under National Coverage Determination (NCD) 190.17. Coverage is not blanket. The NCD identifies three covered indications: monitoring anticoagulant therapy, diagnosis and management of bleeding disorders, and evaluation of liver function. Testing ordered outside these indications requires a signed ABN (Advance Beneficiary Notice) before the draw.

Routine insurance eligibility verification before scheduling coagulation labs tells you which rules a Medicare Advantage plan follows. Some plans apply the same NCD criteria. Others apply a more restrictive Local Coverage Determination (LCD) through their MAC (Medicare Administrative Contractor). MAC-level LCDs can impose frequency limits beyond the national policy, so always check the MAC serving your state.

Point-of-care PT/INR testing (performed in the office rather than sent to a reference lab) may qualify as CLIA-waived under specific device approvals. CLIA-waived status is device-specific, not a blanket classification. The FDA maintains the list of CLIA-waived tests. If your office performs POCT with a CLIA-waived device, append modifier QW to 85610. Billing without QW when the device is waived, or adding QW when it is not, both generate claim edits.

CPT 85610 reimbursement rates and 2026 fee schedule

CPT code 85610 is a clinical diagnostic laboratory test, so Medicare pays it under the Clinical Laboratory Fee Schedule (CLFS). It is not paid under the Medicare Physician Fee Schedule (MPFS). On the physician fee schedule the code carries status indicator X, a statutory exclusion. CMS assigns it no work, practice expense, or malpractice RVUs, so there is no RVU breakdown to look up and no MPFS payment to calculate.

The CLFS pays a single national amount per test. PAMA replaced the old local fee and national limitation amount structure on January 1, 2018. Since then the rate has been uniform across the country, with no locality adjustment and no facility versus non-facility differential. The 2026 national payment amount for 85610 is approximately $4.29.

That single national figure makes the margin math on in-house PT/INR testing simple. Medicare pays about $4.29 per test wherever you are, so the only variables you control are cuvette or strip cost, staff time, and instrument maintenance. Practices running high monthly volumes should price those inputs against the CLFS amount before committing to point-of-care testing.

Download the current file from the CMS Clinical Laboratory Fee Schedule page before you set posting amounts in your billing system. You can also submit claims via Claim.MD, Pabau’s integrated clearinghouse partner, which applies current CMS fee schedule data at claim submission.

Commercial payer and self-pay rates for 85610

Commercial payers set their own allowables for 85610 and usually publish them in a laboratory exhibit attached to your contract. Those exhibits are typically expressed as a percentage of the CLFS amount, not of the physician fee schedule. Check the lab exhibit rather than assuming your general professional-services percentage applies.

Self-pay pricing is set by the practice or the reference lab. Publish that price where patients can find it before the draw, and keep it consistent with the good faith estimate you give uninsured patients. Load the contracted and self-pay amounts into your practice management system so expected reimbursement posts correctly.

Automate your lab billing workflows

Pabau links CPT codes to lab orders, attaches supporting ICD-10 codes, and sends claims through your clearinghouse without manual re-entry. See how coagulation billing fits into your full revenue cycle.

Book a demo

Documentation requirements for CPT 85610

Correct medical billing compliance for 85610 starts with the order. Every claim needs a paper trail that auditors can follow from the physician order to the reported result. These are the required documentation elements.

• Physician order. A signed, dated order from the treating provider specifying the PT/INR test. Verbal orders must be countersigned within the payer’s required timeframe.
• Medical necessity documentation. The encounter note must state the clinical indication. For warfarin monitoring, note the medication, dose, and therapeutic target range. For bleeding disorder workup, describe the presenting symptoms.
• Diagnosis code linkage. The ICD-10-CM code on the claim must match the documented indication. Mismatches between the encounter note and the claim are a primary audit trigger.
• Frequency justification. For patients tested more often than MAC frequency guidelines allow, document clinical necessity in the record. Dose adjustments, supratherapeutic INR values, and new medication interactions all justify increased testing frequency.
• Result documentation. The lab result (PT in seconds, INR value, normal range) must be filed in the medical record and linked to the ordering encounter.

For practices generating a superbill at the point of care, attach the lab order number and the collected specimen time. Independent labs billing under their own NPI still need the referring physician’s NPI and a copy of the original order.

Modifier usage for CPT code 85610

Four modifiers appear regularly on 85610 claims. Using the wrong one, or omitting a required one, triggers edits at the clearinghouse or payer level.

Billing 85610 with an E/M code on the same date

A patient may present for a warfarin management visit and have a PT/INR ordered at the same encounter. Both the E/M code and 85610 can be billed separately. The key requirement: the E/M must represent a significant, separately identifiable service beyond the lab order itself. Append modifier 25 to the E/M code to signal this distinction.

If the visit consists solely of reviewing a PT result and adjusting the warfarin dose, payers may argue the E/M is not separately identifiable. Document the complexity of the management decision in the encounter note to support the separate E/M charge.

Place of service and who bills 85610

Place of service does not change what Medicare pays for 85610. The CLFS amount is identical in a physician office (POS 11), an independent laboratory (POS 81), or a hospital outpatient department (POS 22). What place of service does signal is which entity performed the test and under whose CLIA certificate.

If your practice runs the test in-house on its own CLIA certificate, bill 85610 with POS 11. If you collect the specimen and send it to a reference lab, that lab bills 85610 under its own NPI. Your practice bills only the collection service, using 36415 where the payer covers it. Never bill 85610 twice for the same specimen from two entities unless each is billing a distinct service.

CPT 85610 vs 85611: What is the difference?

CPT 85611 describes a substitution prothrombin time, also called an inhibitor screen or factor substitution study. It is not an alternative way to bill the routine PT/INR test. The two codes serve different clinical purposes.

Related coagulation codes: 85613 and 85730

Coagulation workups frequently include multiple panel codes ordered together. Understanding how these codes interact prevents both undercoding and inadvertent bundling errors. The AAPC’s coding guidelines note that these codes each represent a distinct test methodology and can be reported together when separately performed and medically necessary.

When billing 85610 and 85730 together as a coagulation panel, check whether your payer requires a bundled panel code instead of the individual component codes. Some payer LCD policies bundle coagulation codes if ordered together routinely.

Common billing errors and denial reasons for CPT 85610

The majority of 85610 denials fall into a handful of predictable categories. Effective denial management means knowing which of these patterns your practice generates most frequently and fixing the upstream workflow before claims leave the building.

• Missing or unsigned physician order. Labs billed without a documented order are the leading compliance risk. Payers and auditors treat an unsigned or undated order as no order at all.
• ICD-10 code mismatch. The diagnosis code on the claim does not match the indication documented in the encounter note. This is caught in pre-payment edit sweeps by nearly every payer.
• Exceeding frequency limits without documentation. MAC LCDs for PT testing often specify a covered frequency (e.g., once per month for stable warfarin patients). Testing beyond that frequency requires documented clinical justification in the record, not just the order.
• Wrong modifier placement. Appending modifier 25 to 85610 instead of to the E/M code, or using modifier 91 without a documented clinical reason for the repeat test.
• CLIA-waiver mismatch. Billing POCT without the QW modifier when using a CLIA-waived device. Adding QW when a reference lab processed the specimen fails the same edit.
• Duplicate billing. Submitting 85610 twice on the same date when only one specimen was collected. This usually happens when a coder bills PT and INR as separate services.

Understanding the denial codes in medical billing that accompany rejected 85610 claims helps coders route appeals correctly. Two CARC codes show up most often on 85610 denials. CO-4 means the procedure is inconsistent with the modifier used. CO-57 means the information submitted does not support this level, frequency, or duration of service. CO-57 is the frequency-limit code, not the prior authorization code. Prior authorization denials return CO-197 instead. Pabau’s electronic remittance advice parsing pulls these denial reason codes into the claim record. Your billing team sees the reason without opening each ERA file.

How Pabau supports lab billing and CPT code workflows

Most coagulation billing errors happen between the lab order and the claim. A clinician orders a PT/INR and the specimen is collected. A separate billing workflow then converts that order by hand into a CPT code with the right ICD-10 pairing. That handoff is where codes get dropped, diagnoses get mislinked, and modifiers get missed.

Pabau’s claims management software connects the lab order directly to the claim. When a provider creates a PT/INR lab order in the patient record, the system attaches CPT code 85610. It then prompts for the supporting diagnosis code from the patient’s active problem list and queues the claim. The medical billing workflow runs within the same platform as the clinical record, removing the re-entry step entirely.

This matters most in cardiology, internal medicine, and anticoagulation practices running high monthly PT volumes. A single missed modifier or ICD-10 mismatch, repeated across hundreds of claims, adds up to serious write-off exposure. Pabau also integrates with Claim.MD. Claims pass through pre-submission edits that check for the error patterns described above before reaching the payer. You can read more about revenue cycle management practices that reduce this kind of exposure across your full billing stack.

For practices running their own POCT with a CLIA-waived device, Pabau’s lab management software tracks which device performed the test. It then flags the QW modifier automatically when the claim is generated. That is the kind of operational detail that manual billing workflows consistently miss.

Conclusion

CPT code 85610 is a high-volume, low-complexity code that should be straightforward to bill. The denials that practices see consistently come from the same upstream failures: missing orders, wrong ICD-10 codes, frequency overruns without documentation, and modifier errors. Fix those workflows and 85610 becomes one of the cleanest codes on your remittance report.

Pabau’s integrated claims workflow connects the lab order straight to the claim. It links CPT 85610 to the right diagnosis code and applies the correct modifier. Claims then route through Claim.MD’s pre-submission edit engine before they reach your payer. To see how it works in a live anticoagulation or hematology practice, book a demo.

Continue your research

Want to understand how claims flow from order to payment? Revenue cycle management fundamentals explains the full billing lifecycle from patient scheduling through ERA reconciliation.

Seeing denials you can’t trace? Denial management in healthcare covers how to categorize, appeal, and prevent the most common claim rejection patterns.

Need to clean up your claim submission process? Submitting a clean claim walks through the pre-submission checklist that prevents the majority of first-pass denials.

Frequently asked questions